IP Library › Granted Patent US 10,906,872
Granted Patent B2
US 10,906,872 · App. 16/687,394 · Granted Feb 2, 2021

Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide

Inventors: Michael C. Van Zandt (Guilford, CT); Jennifer L. Savoy (Killingworth, CT)
Assignee: Calithera Biosciences, Inc.
C07D207/16C07B57/00C07C231/12C07C233/05C07C233/57C07C233/65C07C235/06C07C327/22C07D207/06C07F5/025C07B2200/07C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,906,872
App. No.
16/687,394
Granted
Feb 2, 2021
Kind
B2
Abstract

A method is provided to conveniently separate racemic (3R,4S)-3-acetamido-4-allyl-N-(tert-butyl)pyrrolidine-3-carboxamide and (3S,4R)-3-acetamido-4-allyl-N-(tert-butyl)pyrrolidine-3-carboxamide using selective crystallization with chiral carboxylic acids.

Claims (45)

1. A salt of an amine compound represented by formula I and a carboxylic acid compound represented by formula A or B:

wherein:

X is O, S, or NR e ;

R a is H, lower alkyl, or lower cycloalkyl;

R b is —CH 2 CH═CH 2 , —(CH 2 ) n CH 2 Z 1 , —(CH 2 ) n C(O)H, or —(CH 2 ) n CO 2 Z 2 ;

R c and R d are independently H, lower alkyl, lower cycloalkyl, silyl, acyl, acyloxy; or R c and R d , together with the N that links them, form an optionally substituted 3- to 6-membered heteroaryl or heterocyclic ring;

R e is H or lower alkyl;

n is 1 or 2;

Z 1 is halogen, alkyl sulfonate, aryl sulfonate, or an alkyl sulfonate optionally substituted with one or more halogen;

Z 2 is H, lower alkyl, or lower cycloalkyl;

A 1 is phenyl or 5-6 membered heteroaryl, and is optionally substituted by up to 4 R 4 ;

A 2 is phenyl or 5-6 membered heteroaryl, and is optionally substituted by up to 4 R 5 ;

R 1 is lower alkyl or lower cycloalkyl;

R 2 and R 3 are independently H, lower alkyl, or lower cycloalkyl; or R 2 and R 3 , together with the N that links them, form an optionally substituted 3- to 6-membered saturated heterocyclic ring optionally containing 1 or 2 additional heteroatoms selected from S or O; and

R 4 and R 5 are independently halogen, hydroxyl, nitro, lower alkyl, or lower cycloalkyl.

2. The salt of claim 1 , wherein A 1 and A 2 are phenyl.

3. The salt of claim 1 , wherein A 1 is substituted by one R 4 and A 2 is substituted by one R 5 .

4. The salt of claim 1 , wherein the carboxylic acid compound is represented by formula A or B-I:

5. The salt of claim 1 , wherein the amine compound in the salt has an enantiomeric excess of at least 75% ee.

6. The salt of claim 5 , wherein the carboxylic acid compound in the salt is essentially a single enantiomer.

7. The salt of claim 1 , wherein R a is tent-butyl.

8. The salt of claim 1 , wherein R b is —CH 2 CH═CH 2 .

9. The salt of claim 1 , wherein R c is H.

10. The salt of claim 1 , wherein R d is acetyl or trifluoroacetyl.

11. The salt of claim 1 , wherein X is NH.

12. The salt of claim 1 , wherein X is O.

13. The salt of claim 1 , wherein the amine compound is:

14. The salt of claim 1 , wherein the carboxylic acid compound is represented by formula A.

15. The salt of claim 14 , wherein R 1 is methyl.

16. The salt of claim 1 , wherein the carboxylic acid compound is represented by formula B.

17. The salt of claim 4 , wherein the carboxylic acid compound is represented by formula B-I.

18. The salt of claim 16 , wherein R 2 and R 3 are independently methyl, ethyl, or isopropyl; or R 2 and R 3 , together with the N that links them, form a pyrrolidinyl.

19. The salt of claim 17 , wherein R 4 is methyl.

20. The salt of claim 17 , wherein R 5 is methyl.

21. The salt of claim 1 , wherein the carboxylic acid compound is:

22. A method of preparing the salt of claim 1 by fractional crystallization, comprising:

preparing a crystallization solution comprising the amine compound, essentially a single enantiomer of the carboxylic acid compound, and a solvent; and

crystallizing from the crystallization solution the salt of the amine compound and the carboxylic acid compound.

23. The method of claim 22 , wherein the solvent comprises water, methanol, ethanol, isopropanol, ethyl acetate, or acetonitrile or a mixture of any of these.

24. The method of claim 22 , wherein the amine compound in the salt crystallized from the crystallization solution is enantiomerically enriched relative to the amine compound present in the crystallization solution prior to crystallization.

25. The method of claim 22 , wherein the amine compound in the crystallization solution is racemic.

26. The method of claim 22 , wherein the amine compound in the crystallization solution is enantiomerically enriched.

27. The method of claim 22 , wherein preparing the crystallization solution comprises:

preparing a precursor solution comprising the amine compound, a second enantiomer of the amine compound, and a second enantiomer of the carboxylic acid compound;

crystallizing from the precursor solution the salt of the second enantiomer of the amine compound with the second enantiomer of the carboxylic acid compound, thereby forming the crystallization solution as the supernatant.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2023
From: CALITHERA BIOSCIENCES, INC.
To: PRECISION PHARMACEUTICALS, INC.
Reel/Frame 064091/0777 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2020
From: VAN ZANDT, MICHAEL C.; SAVOY, JENNIFER
To: NEW ENGLAND DISCOVERY PARTNERS, LLC
Reel/Frame 053924/0534 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2020
From: NEW ENGLAND DISCOVERY PARTNERS, LLC
To: CALITHERA BIOSCIENCES, INC.
Reel/Frame 053924/0569 →
Continuity (3)
Division 15977948 · May 11, 2018
Provisional Application 62505282 · May 12, 2017
Related Publication 20200087255A1 · Mar 19, 2020